Workflow
RIKE CHEM(300214)
icon
Search documents
日科化学(300214) - 2020 Q4 - 年度财报
2021-03-01 16:00
Financial Performance - The company's operating revenue for 2020 was CNY 2,274,586,718.45, a decrease of 6.01% compared to 2019[25]. - The net profit attributable to shareholders for 2020 was CNY 207,036,161.13, an increase of 16.37% from 2019[25]. - The net cash flow from operating activities increased by 240.11% to CNY 463,349,034.97 in 2020[25]. - The total assets at the end of 2020 were CNY 2,269,233,836.41, reflecting a growth of 10.17% compared to the end of 2019[25]. - The basic earnings per share for 2020 were CNY 0.49, up 16.67% from CNY 0.42 in 2019[25]. - The weighted average return on equity for 2020 was 11.28%, an increase from 10.51% in 2019[25]. - The company reported a net profit of CNY 201,378,078.03 after deducting non-recurring gains and losses, an increase of 11.13% from 2019[25]. - The company's main business revenue decreased by 5.71% year-on-year, with main product sales remaining relatively stable[40]. - The company's net profit attributable to shareholders increased by 16.37% year-on-year, amounting to approximately ¥207.04 million[49]. - The total operating revenue for 2020 was ¥2,274,586,718.45, a decrease of 6.01% compared to ¥2,420,120,333.77 in 2019[60]. Acquisitions and Investments - The company acquired 100% equity of Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. and all shares held by Liu Wei in Binzhou Ocean Chemical Co., Ltd. for a total transaction price of 77.08 million RMB[8]. - The company acknowledges the risk of not achieving expected outcomes from acquisitions, particularly if the acquired entities do not resume normal operations[8]. - The company completed the acquisition of 100% equity in Shandong Huibin Cotton Spinning and Dyeing Co., Ltd. for a total transaction price of 77.08 million RMB, enhancing its upstream industry chain[116]. - The company acquired 100% equity of Binzhou Ocean Chemical Co., Ltd., marking a significant merger under non-similar control[66]. - The company plans to invest in a project with an annual production capacity of 330,000 tons of new polymer materials, which is currently under construction[93]. Research and Development - Total R&D expenditure for 2020 was approximately ¥33.76 million, accounting for 1.48% of total revenue, with an increase in R&D personnel to 135[72]. - The company is in the promotion and improvement phase for several R&D projects, including CPVC fire pipe formulations and low-density PVC foam materials[69]. - The company aims to enhance the strength, toughness, and dispersion of plastic products through continuous innovation[50]. - The company has established ACR and ACM divisions to enhance customer service and product development[35]. - The company has a strong focus on research and development, with key personnel involved in numerous IPO and refinancing projects, indicating a robust investment strategy[190][191]. Market and Competition - The company faces risks from fluctuations in raw material prices, particularly for methyl methacrylate and polyethylene, which could impact gross margins and future profitability[6]. - The company emphasizes the importance of maintaining a competitive edge in cost optimization, technological innovation, and new product development to avoid declining product gross margins due to intensified market competition[9]. - The company recognizes the risk of declining product gross margins due to intensified competition and plans to innovate its business model and improve cost efficiency[114]. - The PVC modification agent industry is experiencing growth due to improved domestic market demand driven by national security and environmental policies, as well as rising living standards[102]. - The demand for plastic profiles is expected to continue growing, supported by policies promoting the use of plastic over wood and steel, particularly in energy-saving construction[102]. Safety and Compliance - The company’s production involves hazardous chemicals, necessitating strict safety protocols to prevent accidents that could significantly disrupt operations[10]. - Safety risks associated with hazardous chemicals in production are being addressed through comprehensive safety management systems and training programs[115]. - The company has established comprehensive facilities for safety risk prevention and management, with no major safety incidents reported during the period[158]. - The company was removed from the safety production dishonesty blacklist on August 20, 2020, which had been affecting its project applications and government funding[161]. Shareholder and Governance - The company reported a cash dividend of 0.85 RMB per 10 shares, with a total of 419,902,614 shares eligible for distribution after accounting for repurchased shares[12]. - The total distributable profit for the year 2020 is 450,260,637.63 RMB, with a cash dividend amounting to 35,691,722.19 RMB, representing 100% of the profit distribution[125]. - The company has maintained a cash dividend payout ratio of at least 80% in accordance with its profit distribution policy during its mature development stage[125]. - The company has fulfilled its commitments regarding the non-transfer of shares held by directors and senior management for a period of 36 months post-IPO[128]. - The company has committed to timely and accurate disclosure of all significant information affecting investors, adhering to regulatory oversight[129]. Financial Management - The net cash flow from investing activities decreased by 106.19% to -¥327,522,295.56, mainly due to the acquisition of Binzhou Ocean Chemical by the wholly-owned subsidiary[74]. - The net cash flow from financing activities decreased by 362.91% to -¥115,201,313.25, primarily due to a significant reduction in short-term borrowings by the wholly-owned subsidiary[74]. - The total cash and cash equivalents increased by 133.53% to ¥15,341,585.80, compared to a decrease in the previous year[73]. - The company has engaged in wealth management by investing a total of CNY 50,700 million in bank financial products, with an outstanding balance of CNY 11,000 million[154]. - The company has shown a proactive approach in managing its financial risks through structured guarantees[149]. Employee and Management - The company employed a total of 971 staff, with 688 in production, 54 in sales, 135 in technical roles, 17 in finance, and 77 in administration[198]. - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to CNY 3.6492 million[196]. - The management team is composed of individuals with extensive experience in finance and investment, which is expected to drive future growth and market expansion[192][193]. - The company plans to enhance employee skills through internal training programs, supplemented by occasional external training sessions[200]. - The company has no stock incentive plans for directors and senior management during the reporting period[198].
日科化学(300214) - 2020 Q3 - 季度财报
2020-10-29 16:00
Financial Performance - Net profit attributable to shareholders increased by 35.65% to CNY 63,665,913.85 for the reporting period[7] - Basic earnings per share rose by 36.36% to CNY 0.15 for the reporting period[7] - Operating income decreased by 10.01% to CNY 573,493,546.23 compared to the same period last year[7] - The net profit for the current period is CNY 26,929,005.83, down 29.6% from CNY 38,331,057.12 in the previous period[54] - The net profit attributable to the parent company for Q3 2020 was CNY 63,665,913.85, an increase of 35.6% compared to CNY 46,935,399.19 in Q3 2019[44] - The company reported a net profit of CNY 180,772,463.95 for the year-to-date, a significant increase of 53.8% from CNY 117,396,267.98 in the previous year[51] Assets and Liabilities - Total assets increased by 6.52% to CNY 2,194,005,679.42 compared to the end of the previous year[7] - The total number of ordinary shareholders at the end of the reporting period was 16,823[11] - Total liabilities decreased to CNY 295,759,853.53 from CNY 317,091,302.36, showing a reduction in financial obligations[39] - Current liabilities totaled CNY 123,583,099.96, with accounts payable at CNY 45,210,636.22 and other payables at CNY 30,294,067.58[69] - Owner's equity reached CNY 1,491,893,339.96, including retained earnings of CNY 437,043,844.49 and capital reserve of CNY 596,035,371.08[69] Cash Flow - Cash flow from operating activities showed a significant decline of 761.65% to -CNY 53,640,095.61[7] - Net cash flow from operating activities increased by 741.49% year-on-year, mainly due to a decrease in procurement expenditures compared to the same period last year[19] - The company reported a net cash flow from operating activities of CNY 264,736,932.32, a significant improvement from a negative cash flow of CNY 41,269,305.48 in the previous period[57] - The cash flow from operating activities reflects a strong recovery, suggesting improved operational efficiency and profitability[61] Financial Management - Financial expenses increased by 435.59% year-on-year, mainly due to foreign exchange rate fluctuations[18] - The financial expenses for the year-to-date were CNY 8,799,728.62, compared to a negative CNY 2,622,136.03 in the previous year, indicating a shift in financial management[49] - The company incurred a financial expense of CNY 2,410,758.22, compared to a financial income of CNY 5,193,134.38 in the previous period[53] Shareholder Information - The company reported a commitment not to transfer or entrust shares held prior to the IPO for 36 months from the date of listing[24] - Shareholders are restricted from transferring more than 25% of their total shares during their tenure as directors or senior management, and for six months after leaving[24] - The controlling shareholder has guaranteed that their assets and credit status are sound, with no outstanding debts or legal disputes affecting their ability to contribute capital[24] Research and Development - Research and development expenses for Q3 2020 were CNY 3,451,825.82, up from CNY 2,526,442.05, highlighting a focus on innovation[43] - Research and development expenses increased to CNY 8,559,147.17 for the year-to-date, compared to CNY 8,459,587.51 in the previous year, indicating a focus on innovation[49] - Research and development expenses increased to CNY 7,354,543.84, up 42.6% from CNY 5,155,771.30 in the previous period[53] Compliance and Governance - The company confirmed compliance with relevant regulations regarding non-public stock issuance and has not provided financial assistance to investors in this context[24] - There are no reported violations of securities regulations by the company or its affiliates in relation to the non-public stock issuance[24] - The company has established measures to ensure that management does not engage in unrelated investments or consumption using company assets[24] Strategic Initiatives - The company is focusing on market expansion and new product development as part of its strategic initiatives moving forward[44] - The company has committed to ensuring that executive compensation is linked to the performance of the company's share incentive plans[24]
日科化学:关于参加山东辖区上市公司投资者网上集体接待日活动的公告
2020-09-24 09:10
证券代码:300214 证券简称:日科化学 公告编号:2020-038 山东日科化学股份有限公司 关于参加山东辖区上市公司投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,便于广大投资者全面地了解公司经营发 展等情况,山东日科化学股份有限公司(以下简称"公司")将参加"山东辖区 上市公司2020年度投资者网上集体接待日"活动,现将有关事项公告如下: 本次投资者网上集体接待日活动将通过深圳市全景网络有限公司提供的互 联网平台举行,投资者可以登录"全景·路演天下"(http://rs.p5w.net)参与公 司本次投资者网上集体接待日活动,互动交流时间为2020年9月29日(星期二) 下午15:00至16:55。 届时公司副总经理兼董事会秘书田志龙先生将通过网络在线形式与投资者 进行沟通交流,欢迎广大投资者积极参与。 特此公告。 山东日科化学股份有限公司 董 事 会 二○二○年九月二十四日 ...
日科化学(300214) - 2020 Q2 - 季度财报
2020-08-24 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was CNY 1,106,671,561.24, representing a 1.88% increase compared to CNY 1,086,228,952.46 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was CNY 117,106,550.10, a significant increase of 66.20% from CNY 70,460,868.79 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was CNY 115,861,350.53, up 67.88% from CNY 69,012,856.42 year-on-year[22]. - The basic earnings per share rose to CNY 0.28, reflecting a 64.71% increase from CNY 0.17 in the previous year[22]. - The operating profit reached ¥156,518,250.26, reflecting a significant growth of 69.36% year-on-year[40]. - The company reported a total of 5,910,000 shares repurchased, accounting for 1.39% of the total share capital, with a total expenditure of 39,950,656 RMB[120]. - The net profit margin for the first half of 2020 was approximately 6.3%, reflecting the company's profitability[167]. Cash Flow and Liquidity - The net cash flow from operating activities reached CNY 318,377,027.93, a remarkable increase of 1,008.51% compared to a negative cash flow of CNY 35,044,020.33 in the same period last year[22]. - The company reported a net cash flow from operating activities of 318,377,027.93 yuan, a significant increase of 1,008.51% compared to the previous year[44]. - The company's cash and cash equivalents increased significantly to CNY 246,947,724.15 from CNY 121,061,622.20, a growth of about 104.5%[148]. - The cash and cash equivalents at the end of the period reached ¥412,544,502.91, up from ¥189,185,460.08 at the beginning of the period[161]. - The total cash inflow from operating activities amounted to ¥1,228,983,064.17, while cash outflow was ¥910,606,036.24, resulting in a net cash inflow of ¥318,377,027.93[161]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,168,918,960.77, a 5.30% increase from CNY 2,059,758,821.15 at the end of the previous year[22]. - The total liabilities at the end of the reporting period were CNY 430,270,800, reflecting the company's financial obligations[177]. - Owner's equity rose to CNY 1,859,774,068.88, up from CNY 1,742,667,518.79, marking an increase of approximately 6.7%[146]. - The actual guarantee total accounted for 3.97% of the company's net assets[108]. Research and Development - Research and development expenses decreased by 77.26% to 5,210,041.43 yuan, mainly due to reduced investment caused by the pandemic[44]. - The company is actively involved in the research and development of plastic modifiers and additives, focusing on improving product offerings[64]. - The company plans to continue its investment in research and development to innovate and improve product quality[107]. Market and Product Performance - The sales volume of main business products increased by 13.29% compared to the same period last year[40]. - ACR product sales increased by 22.09% year-on-year, generating revenue of 340,601,509.51 yuan, but overall revenue from ACR products decreased by 12.54% due to price adjustments[41]. - ACM product sales grew by 12.30% year-on-year, achieving revenue of 753,769,784.63 yuan, with a year-on-year increase of 15.35%[41]. - The company's main products include ACR, ACM, and ACS, with revenue contributions of 30.78%, 68.11%, and 0.90% respectively[30]. Risks and Challenges - The company faces risks related to raw material price fluctuations, accounts receivable, investment projects, and potential underperformance of acquisitions[5][6][8][9]. - The increase in accounts receivable poses liquidity and bad debt risks, prompting the company to enhance customer selection and collection efforts[76]. - Investment projects are closely tied to the company's strategic development, with risks of lower net asset returns and discrepancies between forecasts and actual performance[77]. - Intensifying competition may lead to declining product gross margins if the company fails to maintain cost optimization and innovation[78]. Corporate Governance and Compliance - The company committed to timely disclosure of significant information affecting investors[90]. - The company has made commitments to avoid conflicts of interest and ensure fair practices among its directors and executives[90]. - The company has ensured compliance with relevant laws and regulations regarding stock issuance and management[90]. - The financial report was approved by the board of directors on August 24, 2020, ensuring timely disclosure of financial performance[183]. Future Outlook - Future outlook indicates a positive trend in revenue growth driven by new product launches and market expansion strategies[107]. - The company plans to focus on expanding its market presence and developing new technologies in the upcoming quarters[168]. - The company is exploring potential mergers and acquisitions to strengthen its market position and expand its product portfolio[168].
日科化学(300214) - 2020 Q1 - 季度财报
2020-04-24 16:00
山东日科化学股份有限公司 Shandong Rike Chemical Co.,LTD. 2020 年第一季度报告 | 股票代码: | | 300214 | | | | | --- | --- | --- | --- | --- | --- | | 股票简称: | | 日科化学 | | | | | 披露日期: | 2020 年 | 4 | 月 | 25 | 日 | 山东日科化学股份有限公司 2020 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整,不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人彭国锋、主管会计工作负责人刘永强及会计机构负责人(会计主 管人员)刘永强声明:保证季度报告中财务报表的真实、准确、完整。 2 山东日科化学股份有限公司 2020 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | - ...
日科化学(300214) - 2019 Q4 - 年度财报
2020-04-20 16:00
Acquisition Plans - The company plans to acquire 100% equity of Shandong Ocean Chemical for RMB 77.08 million, pending internal approvals and asset evaluations[10] - The company has not yet engaged a qualified assessment agency for the investment target in the acquisition, indicating potential risks in achieving expected returns[10] - The company is pursuing a share acquisition of 77.08 million RMB to gain 100% ownership of a chemical company, with potential risks related to achieving expected returns[118] Financial Performance - The company's operating revenue for 2019 was ¥2,420,120,333.77, representing a 54.27% increase compared to ¥1,568,771,296.29 in 2018[24] - The net profit attributable to shareholders for 2019 was ¥177,911,380.66, a 73.12% increase from ¥102,767,774.37 in 2018[24] - The net profit after deducting non-recurring gains and losses reached ¥181,209,287.81, marking a significant increase of 271.75% compared to ¥48,745,322.25 in 2018[24] - The company's cash flow from operating activities was ¥136,236,696.09, up 144.96% from ¥55,615,076.59 in the previous year[24] - The company achieved a total operating revenue of ¥2,420,120,333.77, representing a year-on-year growth of 54.27%[45] - The net profit attributable to shareholders increased by 73.12% to ¥177,911,380.66 compared to the previous year[45] - The main business revenue reached ¥2,407,834,146.57, up 55.87% year-on-year, accounting for 99.49% of total revenue[45] Dividend Policy - The profit distribution plan proposes a cash dividend of RMB 0.6 per 10 shares, based on 419,902,614 shares after accounting for repurchased shares[12] - The total cash dividend for 2019, including other methods, amounted to RMB 58,835,073.97, representing 33.07% of the net profit attributable to shareholders[131] - The cash dividend payout ratio for 2019 was 100%, adhering to the policy that at least 80% of profits should be distributed as cash dividends during mature development stages[125] - The company has maintained a consistent cash dividend distribution policy over the past three years, with clear and transparent decision-making processes[125] Risks and Challenges - The company faces risks from raw material price fluctuations, which could impact gross margins and future profitability[6] - The increase in accounts receivable may lead to liquidity risks or bad debt risks due to changes in customer structure and aging[7] - The COVID-19 pandemic has introduced uncertainties affecting production and operations, potentially impacting export business and performance[11] - The company is addressing accounts receivable risks by carefully selecting customers and linking collection performance to employee evaluations[111] Market and Strategic Focus - The company emphasizes its strategic focus on providing comprehensive solutions in processing aids and impact modifiers to meet customer needs[17] - The company aims to enhance its market position by continuously adapting to customer needs and providing value-added solutions in the PVC plastic modification sector[36] - The domestic market demand for PVC modifiers is expected to improve due to resource conservation and environmental protection policies, as well as new urbanization planning[102] - The company aims to provide comprehensive solutions for PVC processing and rubber industries, leveraging its technical advantages in processing aids and impact modifiers[104] Asset and Capital Management - The company's total assets of the company at the end of 2019 were ¥2,059,758,821.15, a 13.43% increase from ¥1,815,886,977.66 at the end of 2018[24] - The company's fixed assets increased by 14.67% year-to-date, primarily due to the conversion of construction projects into fixed assets[38] - Intangible assets saw a significant increase of 107.28% year-to-date, mainly from land use rights acquired for new projects[38] - The company’s capital reserve balance stood at RMB 596,035,371.08 as of the end of the reporting period[127] Shareholder Information - The company’s total share capital is 425,812,614 shares, with 5,910,000 shares held in the repurchase account[12] - The company completed a share buyback of 5,910,000 shares, accounting for 1.39% of total share capital, at a total cost of ¥39,950,656[48] - The largest shareholder, Zhao Dongri, holds 20.00% of the shares, totaling 85,162,523 shares, with a decrease of 25,260,263 shares during the reporting period[186] - The company does not have a single actual controller, as the shareholding structure is relatively dispersed among multiple stakeholders[191] Compliance and Governance - The company has committed to ensuring that its periodic reports are accurate, complete, and timely disclosed to investors[133] - The company has fulfilled its commitments regarding non-public stock issuance and has not violated relevant regulations[133] - The company has committed to adhering to all relevant laws and regulations regarding securities issuance and management[133] - The company did not report any non-standard audit reports for the reporting period[136]
日科化学(300214) - 2019 Q3 - 季度财报
2019-10-24 16:00
Financial Performance - Net profit attributable to shareholders rose by 70.35% to CNY 46,935,399.19 for the reporting period[8] - Operating revenue for the period reached CNY 637,318,021.40, reflecting a 24.83% increase year-on-year[8] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 80.64% to CNY 46,861,073.90[8] - Basic earnings per share increased by 83.33% to CNY 0.11[8] - The weighted average return on equity improved to 2.85%, up from 1.10% in the previous year[8] - Total operating revenue for the current period reached ¥637,318,021.40, an increase of 24.8% compared to ¥510,539,381.47 in the previous period[44] - Net profit for the current period was ¥46,935,399.19, representing a 70.5% increase from ¥27,552,283.84 in the same period last year[45] - The total comprehensive income for the current period was ¥46,935,399.19, compared to ¥27,552,283.84 in the previous period[46] Assets and Liabilities - Total assets increased by 6.19% to CNY 1,928,253,805.02 compared to the end of the previous year[8] - Current liabilities rose to CNY 229,255,579.26, compared to CNY 193,074,753.73 in the previous year, indicating an increase of about 18.7%[37] - Total liabilities amounted to CNY 229,855,388.29, up from CNY 194,221,162.82, indicating an increase of about 18.4%[37] - Non-current assets totaled CNY 752,871,260.23, compared to CNY 723,376,984.26, reflecting an increase of approximately 4.1%[36] - The company's total equity attributable to shareholders increased to CNY 1,698,398,416.73 from CNY 1,621,665,814.84, a growth of about 4.7%[38] Cash Flow - The company reported a net cash flow from operating activities of CNY -41,269,305.48, a decrease of 340.76% compared to the previous year[8] - Cash and cash equivalents decreased by 50.33% compared to the beginning of the period, mainly due to increased raw material reserves and receivables, as well as payments for land deposits[17] - Cash outflow from investing activities was CNY 73,935,220.85, up from CNY 11,222,336.67 in the previous year, indicating increased investment expenditures[58] - Cash flow from financing activities resulted in a net outflow of CNY -44,618,289.33, compared to CNY -41,075,695.22 in the same period last year[58] - The ending cash and cash equivalents balance decreased to CNY 77,507,736.99 from CNY 249,138,581.42, showing a significant decline[58] Shareholder Information - The total number of shareholders at the end of the reporting period was 15,166[11] - The top shareholder, Zhao Dongri, holds 20.00% of the shares, totaling 85,162,523 shares[11] - The company repurchased 4,172,900 shares, accounting for 0.98% of the total share capital, with a total payment of approximately RMB 25.75 million[24] - The company plans to repurchase shares at a price not exceeding RMB 7 per share, with a total repurchase amount not less than RMB 30 million and not exceeding RMB 35 million[24] Operational Metrics - Operating costs increased by 63.62% compared to the same period last year, in line with the increase in operating revenue[19] - Research and development expenses increased to ¥2,526,442.05, up 29.5% from ¥1,950,673.31 in the previous period[44] - Total operating costs amounted to ¥571,985,701.15, up 20.0% from ¥476,604,214.32 in the prior period[44] - Operating profit for the current period was ¥63,245,190.56, a 81.5% increase from ¥34,855,221.23 in the previous period[45] Compliance and Governance - The company has committed to not transferring or entrusting shares held prior to the IPO for a period of 36 months from the date of listing[27] - Shareholders are restricted to transferring no more than 15% of their total shares annually during their tenure as directors or senior management, and cannot transfer shares within six months after leaving[27] - The company and its related parties have complied with regulations regarding non-public stock issuance, ensuring no financial assistance or compensation was provided to investors[27] - The controlling shareholder has guaranteed that their asset and credit status is sound, with no defaults or pending litigation affecting their ability to contribute capital[27] - The company has committed to maintaining diligent and faithful performance of duties to protect the interests of the company and all shareholders[27] Miscellaneous - The company reported no violations regarding external guarantees during the reporting period[30] - There were no non-operating fund occupations by controlling shareholders or related parties during the reporting period[31] - The company has committed to ensuring that all significant information affecting investors is disclosed accurately and timely[29] - The company is focused on eliminating competition with related parties through acquisition or transfer of competing businesses[29]
日科化学(300214) - 2019 Q2 - 季度财报
2019-08-29 16:00
Financial Performance - Total revenue for the first half of 2019 reached ¥1,086,228,952.46, representing a 110.56% increase compared to ¥515,875,508.69 in the same period last year[22]. - Net profit attributable to shareholders was ¥70,460,868.79, up 20.93% from ¥58,267,772.12 year-on-year[22]. - Net profit after deducting non-recurring gains and losses surged by 404.41% to ¥69,012,856.42 from ¥13,681,925.79 in the previous year[22]. - Basic earnings per share increased by 21.43% to ¥0.17 from ¥0.14 in the same period last year[22]. - The company achieved operating revenue of CNY 1,086,228,952.46, a year-on-year increase of 110.56%[41]. - The net profit attributable to shareholders was CNY 70,460,868.79, reflecting a year-on-year growth of 20.93%[41]. - The net profit after deducting non-recurring gains and losses was CNY 69,012,856.42, up 404.41% compared to the previous year[41]. - The total comprehensive income for the first half of 2019 was CNY 70,460,868.79, up 20.9% from CNY 58,267,772.12 in the first half of 2018[165]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,909,616,895.19, a 5.16% increase from ¥1,815,886,977.66 at the end of the previous year[22]. - Current assets totaled CNY 1,202,520,012.96 as of June 30, 2019, compared to CNY 1,092,509,993.40 at the end of 2018, reflecting an increase of approximately 10.0%[151]. - The total liabilities increased to CNY 238,715,287.26 as of June 30, 2019, compared to CNY 194,221,162.82 at the end of 2018, marking an increase of about 22.9%[158]. - The company's total equity attributable to shareholders reached CNY 1,670,901,607.93, up from CNY 1,621,665,814.84, reflecting an increase of approximately 3.0%[158]. Cash Flow - The net cash flow from operating activities was negative at -¥35,044,020.33, a decline of 135.90% compared to ¥97,626,086.28 in the same period last year[22]. - Cash flow from operating activities showed a net outflow of CNY 35,044,020.33 in the first half of 2019, compared to a net inflow of CNY 97,626,086.28 in the same period of 2018[169]. - The company achieved a cash and cash equivalents net decrease of CNY 73,000,104.56 in the first half of 2019, contrasting with a net increase of CNY 76,683,182.55 in the same period of 2018[169]. Operational Highlights - Main business revenue reached CNY 1,075,785,157.63, an increase of 114.66% year-on-year, accounting for 99.04% of total revenue[41]. - Sales volume of ACR impact modifiers increased by 190.05%, generating revenue of CNY 389,415,747.56, a 119.96% increase year-on-year[41]. - The company’s main business cost was CNY 911,558,796.23, which increased by 112.06% compared to the previous year[41]. - The gross profit margin of main business products increased by 1.04 percentage points year-on-year[41]. Research and Development - Research and development expenses rose by 29.51% to RMB 5,933,145.46 from RMB 4,581,156.39, indicating a focus on innovation[45]. - Research and development expenses for the first half of 2019 were CNY 5,933,145.46, compared to CNY 4,581,156.39 in the same period of 2018, representing an increase of about 29.5%[161]. Risks and Challenges - Risks related to raw material price fluctuations and accounts receivable have been highlighted, which may impact future profitability[6][7]. - The company faces risks related to raw material price fluctuations, which could impact gross margins and future profitability[84]. - The company is addressing accounts receivable risks by carefully selecting customers and enhancing collection efforts[85]. - The company faces risks in investment projects due to potential changes in market demand, industry policies, and technological updates, which may lead to a decline in net asset return rates and discrepancies between profit forecasts and actual performance[86]. Shareholder and Governance - The company plans not to distribute cash dividends or issue bonus shares[11]. - The company has not engaged in any entrusted financial management, derivative investments, or entrusted loans during the reporting period[63][64][65]. - The company has not reported any changes in the raised funds project during the reporting period[62]. - The company has committed to maintaining good asset and credit status without any defaults or pending litigations[97]. Subsidiaries and Investments - The company has four wholly-owned subsidiaries: Rike Rubber, Rike New Materials, Guoxin Hengjin Import and Export, and Qiheng New Materials[69]. - Rike Rubber reported a net profit of RMB 42,573,247.78, contributing significantly to the company's overall profitability[69]. - The company established Qiheng New Materials to invest in a project with an annual production capacity of 330,000 tons of new polymer materials[69]. Compliance and Reporting - The financial report for the first half of 2019 was not audited[148]. - The company committed to timely and accurate disclosure of significant information affecting investors[98]. - The company has ensured that all submitted documents to the Shenzhen Stock Exchange are free from false statements or significant omissions[98].
日科化学(300214) - 2019 Q1 - 季度财报
2019-05-19 16:00
Financial Performance - Total revenue for Q1 2019 reached ¥506,686,887.12, representing a 164.96% increase compared to ¥191,229,176.43 in the same period last year[9] - Net profit attributable to shareholders decreased by 24.68% to ¥26,343,648.73 from ¥34,975,050.97 year-on-year[9] - Net profit excluding non-recurring gains and losses surged by 403.30% to ¥25,771,046.49, compared to a loss of ¥8,496,988.02 in the previous year[9] - The company achieved operating revenue of CNY 506,686,887.12 in Q1 2019, a year-on-year increase of 164.96% due to the previous year's production halt caused by an accident[25] - The net profit attributable to shareholders decreased by 24.68% to CNY 26,343,648.73, while the net profit excluding non-recurring gains and losses increased by 403.30% to CNY 25,771,046.49[25] - Total operating revenue for Q1 2019 reached CNY 506.69 million, a significant increase from CNY 191.23 million in the same period last year, representing a growth of 164.5%[63] - Net profit for Q1 2019 was CNY 26.34 million, down from CNY 34.98 million in Q1 2018, reflecting a decrease of 24.6%[65] Cash Flow and Liquidity - Operating cash flow turned negative with a net outflow of ¥45,001,373.36, a decline of 138.01% from a positive cash flow of ¥118,386,096.15 in the same period last year[9] - The company reported a net cash outflow from operating activities of CNY -45,001,373.36, a decrease of 138.01% compared to the previous year[24] - The cash flow from operating activities showed a net outflow of ¥45,001,373.36, a decrease from a net inflow of ¥118,386,096.15 in the previous period[73] - The total cash and cash equivalents at the end of the period were ¥212,125,572.92, down from ¥409,037,176.15 at the end of the previous period[73] - The net cash flow from operating activities for the first quarter was CNY 1,006,771.23, compared to CNY 169,381,342.61 in the previous period[76] - The net increase in cash and cash equivalents was -CNY 3,137,219.05, with a closing balance of CNY 186,687,657.23[76] Assets and Liabilities - Total assets increased by 5.65% to ¥1,918,439,706.53 from ¥1,815,886,977.66 at the end of the previous year[9] - The company's current assets totaled CNY 1,206,719,119.95, up from CNY 1,092,509,993.40 at the end of 2018, reflecting a growth of approximately 10.4%[55] - Accounts receivable increased to CNY 697,342,045.58 from CNY 643,786,595.67, representing a rise of approximately 8.3%[55] - Total liabilities increased to CNY 270,430,242.95 from CNY 194,221,162.82, indicating a growth of about 39.2%[57] - The company's equity remained stable with total equity at CNY 1,647,999,463.58 as of March 31, 2019[57] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,864[12] - The largest shareholder, Zhao Dongri, holds 20.00% of the shares, totaling 85,162,523 shares[12] - The company’s major shareholder changed to Jinhu Investment, holding 21.88% of the total shares after the transfer agreement was completed[39] - As of March 31, 2019, the company has repurchased 1,311,100 shares, accounting for approximately 0.31% of the total share capital, with a total payment of RMB 6,313,792[42] - The company plans to repurchase shares with a total amount not exceeding RMB 1.5 billion and not less than RMB 30 million, with a maximum price of RMB 5 per share[42] Operational Risks and Management - The company is facing risks related to increasing accounts receivable, which may affect liquidity and operational efficiency[37] - The company is implementing measures to improve accounts receivable collection, including careful customer selection and linking collection performance to employee evaluations[37] - The company has identified risks in investment projects due to market demand changes and policy adjustments, and is optimizing project management to maximize returns[34] - The company was placed on the safety production dishonesty blacklist due to a safety accident on December 19, 2017, which may affect project applications and government funding for one year[38] - The company’s asset-liability ratio is low, and it expects no significant impact on its operations from being on the blacklist[40] Research and Development - Research and development expenses for the current period were ¥1,835,367.67, slightly up from ¥1,689,875.47 in the previous period[67] Supplier and Customer Concentration - The company’s top five suppliers accounted for 68.83% of total purchases in Q1 2019, up from 74.74% in the same period last year[28] - The company’s top five customers accounted for 26.71% of total sales in Q1 2019, down from 41.50% in the same period last year[29] Safety Management - The company has completed safety management improvements and received government approval to resume production as of April 12, 2018[33] - The company is committed to enhancing safety management levels to prevent future incidents and ensure normal operations[33]
日科化学(300214) - 2019 Q1 - 季度财报
2019-04-26 16:00
Financial Performance - Total revenue for Q1 2019 reached ¥506,686,887.12, representing a 164.96% increase compared to ¥191,229,176.43 in the same period last year[9] - Net profit attributable to shareholders decreased by 24.68% to ¥26,343,648.73 from ¥34,975,050.97 year-on-year[9] - Net profit excluding non-recurring gains and losses surged by 403.30% to ¥25,771,046.49, compared to a loss of ¥8,496,988.02 in the previous year[9] - The company achieved operating revenue of CNY 506,686,887.12 in Q1 2019, a year-on-year increase of 164.96% due to the previous year's production halt caused by an accident[25] - The net profit attributable to shareholders decreased by 24.68% to CNY 26,343,648.73, while the net profit excluding non-recurring gains and losses increased by 403.30% to CNY 25,771,046.49[25] - The company reported a significant increase in revenue for Q1 2019, with a year-over-year growth of 15%[45] - The total profit for Q1 2019 was CNY 15,695,144.32, down from CNY 51,163,727.55 in the previous year, marking a decline of approximately 69%[66] - The total comprehensive income for Q1 2019 was CNY 11,771,358.24, down from CNY 51,163,727.55 in the previous year, indicating a decrease of about 77%[68] Cash Flow and Liquidity - The net cash flow from operating activities was negative at ¥-45,001,373.36, a decline of 138.01% from ¥118,386,096.15 in the same period last year[9] - The company reported a net cash outflow from operating activities of CNY -45,001,373.36, compared to a net inflow of CNY 118,386,096.15 in the same period last year[71] - Cash inflow from operating activities totaled ¥261,214,074.74, compared to ¥207,301,292.66 in the prior year, reflecting an increase of approximately 26%[74] - The total cash and cash equivalents at the end of the period were ¥186,687,657.23, down from ¥396,491,799.39 in the previous year[75] - The company experienced a net decrease in cash and cash equivalents of -¥3,137,219.05, contrasting with an increase of ¥170,142,003.09 in the prior year[75] Assets and Liabilities - Total assets increased by 9.23% to ¥1,918,439,706.53 from ¥1,756,346,078.12 at the end of the previous year[9] - Total liabilities amounted to ¥270.43 million, compared to ¥194.22 million in the previous year, marking an increase of 39.2%[58] - The company's asset-liability ratio is low, and it expects no significant impact on its operations from being on the blacklist[40] - The total assets of the company were ¥1.62 billion as of March 31, 2019, compared to ¥1.60 billion at the end of 2018, indicating a slight increase of 1.4%[61] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 15,864[12] - The largest shareholder, Zhao Dongri, holds 20.00% of the shares, totaling 85,162,523 shares[12] - The company’s major shareholder changed to Jinhu Investment, holding 21.88% of the total shares after the transfer of shares was completed[39] - As of March 31, 2019, the company has repurchased 1,311,100 shares, accounting for approximately 0.31% of the total share capital, with a total payment of RMB 6,313,792[42] Operational Challenges and Risks - The company is facing risks related to increasing accounts receivable, which may affect liquidity and operational efficiency[37] - The company is implementing measures to improve accounts receivable collection, including careful customer selection and linking collection performance to employee evaluations[37] - The company faces risks of declining product gross margins due to intensified market competition and plans to focus on cost optimization and technological innovation[32] - The company has identified risks in investment projects due to market demand changes and policy adjustments, and is optimizing project management to maximize returns[34] Strategic Initiatives - The company plans to mitigate risks from raw material price fluctuations by implementing strategic procurement strategies and leveraging scale advantages[31] - The company plans to repurchase shares with a total amount not exceeding RMB 1.5 billion and not less than RMB 30 million, with a maximum repurchase price of RMB 5 per share[42] - The company is considering strategic acquisitions to bolster its market position, with a budget of 100 million yuan allocated for potential deals[45] - Market expansion plans include entering two new international markets by the end of 2019, targeting a 10% market share in each[45] Research and Development - The company is investing 50 million yuan in R&D for new technologies aimed at enhancing product efficiency[45] - Research and development expenses for Q1 2019 were ¥2.86 million, compared to ¥2.48 million in Q1 2018, an increase of 15.1%[63] - Research and development expenses for Q1 2019 were CNY 1,835,367.67, slightly up from CNY 1,689,875.47 in the previous year, showing an increase of about 8.6%[66] Compliance and Governance - The company has committed to maintaining transparency and compliance with regulatory requirements in all financial disclosures[45] - The company was placed on the safety production dishonesty blacklist due to a safety incident on December 19, 2017, which may affect project applications and government funding for one year[38] - The company completed safety management improvements and received government approval to resume production as of April 12, 2018[33] - The management team emphasized the importance of sustainable practices in future operations, aiming for a 25% reduction in carbon footprint by 2025[45]